MedTrace Logo

Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program

NCT03042728 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 229

Last updated 2019-01-02

No results posted yet for this study

Summary

In this study the investigators hypothesize that the presence of a Mayo Clinic certified therapy dog will provide additional benefits above typical therapy for patients suffering from fibromyalgia currently enrolled in the Mayo Clinic Fibromyalgia Program.

Conditions

  • Fibromyalgia

Interventions

BEHAVIORAL

Dog Interaction

A therapy dog will visit the patients.

BEHAVIORAL

Human Interaction

A human will visit the patients.

Sponsors & Collaborators

Principal Investigators

  • Arya B Mohabbat · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-07
Primary Completion
2018-10-20
Completion
2018-10-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03042728 on ClinicalTrials.gov